Joseph P. Lucia & Associates, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Joseph P. Lucia & Associates, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	BUY	$595.12 - $698.43 $36,302 - $42,604	61 New	61 $43,000
Q4 2021 Feb 04, 2022	SELL	$543.48 - $670.97 $33,152 - $40,929	-61 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$478.3 - $607.98 $29,176 - $37,086	61 New	61 $29,000
Q3 2020 Oct 20, 2020	SELL	$544.75 - $658.21 $33,229 - $40,150	-61 Closed	0 $0
Q2 2019 Jul 23, 2019	SELL	$299.6 - $414.82 $7.31 Million - $10.1 Million	-24,415 Reduced 99.75%	61 $19,000
Q1 2019 May 02, 2019	BUY	$372.08 - $439.57 $9.11 Million - $10.8 Million	24,476 New	24,476 $61,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.